São Germano Oncologia

Running trials

• Active, not recruiting

  A Study to Investigate Subcutaneous Isatuximab in Combination With Carfilzomib and Dexamethasone in Adult Participants With Relapsed and/or Refractory Multiple Myeloma

  NCT05704049· Phase 2· Source

• Active, not recruiting

  SC Versus IV Isatuximab in Combination With Pomalidomide and Dexamethasone in RRMM

  NCT05405166· Phase 3· Source

• Active, not recruiting

  Oregovomab Plus Chemo in Newly Diagnosed Patients With Advanced Epithelial Ovarian Cancer Following Optimal Debulking Surgery

  NCT04498117· Phase 3· Source

Researchers

No researcher is linked here yet.

Closed trials

• Completed

  A Study to Evaluate Subcutaneous Daratumumab in Combination With Standard Multiple Myeloma Treatment Regimens

  NCT03412565· Phase 2· Source

• Completed

  A Study of Subcutaneous Daratumumab Versus Active Monitoring in Participants With High-Risk Smoldering Multiple Myeloma

  NCT03301220· Phase 3· Source

• Completed

  A Study of Subcutaneous Versus (vs.) Intravenous Administration of Daratumumab in Participants With Relapsed or Refractory Multiple Myeloma

  NCT03277105· Phase 3· Source

• Completed

  A Study to Evaluate the Efficacy and Safety of Daratumumab in Combination With Cyclophosphamide, Bortezomib and Dexamethasone (CyBorD) Compared to CyBorD Alone in Newly Diagnosed Systemic Amyloid Light-chain (AL) Amyloidosis

  NCT03201965· Phase 3· Source

Trial sites

• Clinica Sao Germano4 trials
• Clínica São Germano - Oncologia1 trial
• Clinica São Germano- Site Number : 07600011 trial
• Clinica São Germano- Site Number : 07600031 trial

Conditions

Diseases this institution publishes on or runs trials for.

• Multiple myeloma54 works · 5 trials